Days before pharmaceutical head Martin Shkreli and Kaye Scholer partner Evan Greebel were arrested for fraud, an Eastern District judge ruled that their communications were not privileged.

Court papers unsealed this week show that grand jury subpoenas sought communications between Shkreli, who was CEO of biopharmaceutical company Retrophin until September 2014, and Greebel, who was outside counsel to Retrophin.